AAAAAA
Results:
1-9
|
Results: 9
Authors:
Harris, RJ
Kabakoff, B
Macchi, FD
Shen, FJ
Kwong, M
Andya, JD
Shire, SJ
Bjork, N
Totpal, K
Chen, AB
Citation: Rj. Harris et al., Identification of multiple sources of charge heterogeneity in a recombinant antibody, J CHROMAT B, 752(2), 2001, pp. 233-245
Authors:
Breen, ED
Curley, JG
Overcashier, DE
Hsu, CC
Shire, SJ
Citation: Ed. Breen et al., Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation, PHARM RES, 18(9), 2001, pp. 1345-1353
Authors:
Khossravi, M
Shire, SJ
Borchardt, RT
Citation: M. Khossravi et al., Evidence for the involvement of histidine A(12) in the aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation, BIOCHEM, 39(19), 2000, pp. 5876-5885
Authors:
Jones, LS
Cipola, D
Liu, J
Shire, SJ
Randolph, TW
Citation: Ls. Jones et al., Investigation of protein-surfactant interactions by analytical ultracentrifugation and electron paramagnetic resonance: The use of recombinant human tissue factor as an example, PHARM RES, 16(6), 1999, pp. 808-812
Authors:
Andya, JD
Maa, YF
Costantino, HR
Nguyen, PA
Dasovich, N
Sweeney, TD
Hsu, CC
Shire, SJ
Citation: Jd. Andya et al., The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody, PHARM RES, 16(3), 1999, pp. 350-358
Authors:
Maa, YF
Nguyen, PA
Sweeney, T
Shire, SJ
Hsu, CC
Citation: Yf. Maa et al., Protein inhalation powders: Spray drying vs spray freeze drying, PHARM RES, 16(2), 1999, pp. 249-254
Authors:
Chen, B
Costantino, HR
Liu, J
Hsu, CC
Shire, SJ
Citation: B. Chen et al., Influence of calcium ions on the structure and stability of recombinant human deoxyribonuclease I in the aqueous and lyophilized states, J PHARM SCI, 88(4), 1999, pp. 477-482
Authors:
Liu, J
Shire, SJ
Citation: J. Liu et Sj. Shire, Analytical ultracentrifugation in the pharmaceutical industry, J PHARM SCI, 88(12), 1999, pp. 1237-1241
Authors:
Shire, SJ
Citation: Sj. Shire, Challenges and issues in the development of formulations of protein pharmaceuticals, BIOPHARMACEUTICAL DRUG DESIGN AND DEVELOPMENT, 1999, pp. 205-238
Risultati:
1-9
|